Clinical Trial

A Study to Evaluate the Ability of Sunscreen Products to Modulate the Effects of Deep UVA +/- HEV Blue Light Induced Pigmentation and Biomarkers of Cutaneous Oxidative Stress

Completed
View on ClinicalTrials.gov →
Summary
To assess the level of sub pigmentation following an acute exposure to a Deep Ultraviolet A and high energy Blue Light wavelengths (380-420 nm). This study will compare the unprotected control with test products in Condition #1 and Condition #2 to assess pigmentation as well as cutaneous oxidative stress and inflammation biomarkers that occur with exposure to the same light regimen.
Trial Details
NCT Number NCT07695753
Lead Sponsor Kenvue Brands LLC
Conditions Pigmentation, Oxidative Stress
Enrollment 22 participants
Start Date 2025-10-27
Primary Completion 2025-12-06 (estimated)
Study Completion 2025-12-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-10